Newborn eye imaging systems are medical devices used for screening and diagnosing ocular disorders in infants. These systems use non-invasive retinal imaging techniques such as photo screening to evaluate the condition of retina and other structures of the eye in newborns. The increasing rates of eye disorders such as retinopathy of prematurity (ROP) and cataracts in infants have boosted the demand for newborn eye imaging systems in recent years.
The Global Newborn Eye Imaging Systems Market is estimated to be valued at USD 284.2 Mn in 2025 and is expected to exhibit a CAGR of 5.0% over the forecast period 2025 To 2032.
Key Takeaways
Key players: Key players operating in the newborn eye imaging systems market are System Vision SA, Sanofi-Aventis LLC., Allied Vision Technologies GmbH, Leica Microsystems, Canon Medical Systems, USA., Carl Zeiss Meditec AG, Intelligent Retinal Imaging Systems, Nikon Corporation, Kowa American Corporation, Topcon Europe Medical BV, NextSight, Veatch Ophthalmic Instruments, Boston Micromachines Corporation, Thales Group, Imagine Eyes, SERVICOM MEDICAL (SINGAPORE) PTE LTD., Visunex Medical Systems, Inc., IBM, Remidio Innovative Solutions.
Key opportunities: Newborn Eye Imaging Systems Market Demand is rising awareness about newborn eye screening, increasing willingness to pay for advanced screening technologies, and growing healthcare expenditure in emerging economies present lucrative growth opportunities in the newborn eye imaging systems market.
Global expansion: Key players are focusing on expanding their presence in high potential markets in Asia Pacific and Latin America through partnerships with local medical device companies and hospitals. Countries with large newborn population like China and India are major targets for global expansion.
Market drivers: The primary driver for the newborn eye imaging systems market is the rising prevalence of eye disorders in newborns. According to studies, nearly 50-80% of premature infants develop ROP putting them at high risk of vision impairment. Hence, increased survival of preterm infants indirectly aids market growth. Government initiatives to implement mandatory newborn eye screening programs will also fuel the demand.
PEST Analysis
Political: Government regulations regarding newborn screening programs may impact adoption rates of eye imaging systems. Certain states have mandated conditions for newborn screening by law.
Economic: Healthcare facilities are investing significantly in NICU equipment to provide advanced care to newborns. This is driving demand for eye screening technologies that enable early detection of eye disorders in newborns.
Social: Rising parental awareness about vision impairment conditions in infants and access to timely treatment is increasing demand for newborn eye screening services. This is positively impacting the market.
Technological: Manufacturers are focusing on developing portable and affordable devices integrated with telemedicine capabilities. Automated image analysis solutions are also gaining popularity as they enable efficient screening without requiring specialized skills.
The market in terms of value is concentrated in North America and Europe. Strong presence of leading manufacturers, favorable reimbursement policies, and increasing cases of retinopathy of prematurity are fueling market growth in these regions.
Asia Pacific is the fastest growing regional market for newborn eye imaging systems. This is attributed to rising healthcare expenditure, growing neonatal care facilities, and increasing government initiatives to strengthen newborn screening programs in countries like India and China.
Get This Report in English Language: Newborn Eye Imaging Systems Market
Get This Report in Japanese Language:
Get This Report in Korean Language:
About Author:
Ravina Pandya, Content Writer, has a strong foothold in the market research industry. She specializes in writing well-researched articles from different industries, including food and beverages, information and technology, healthcare, chemical and materials, etc. (https://www.linkedin.com/in/ravina-pandya-1a3984191)
Comments
0 comment